These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 1347252

  • 1. p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency.
    Frankel RH, Bayona W, Koslow M, Newcomb EW.
    Cancer Res; 1992 Mar 15; 52(6):1427-33. PubMed ID: 1347252
    [Abstract] [Full Text] [Related]

  • 2. p53 mutation, EGFR gene amplification and loss of heterozygosity on chromosome 10, 17 p in human gliomas.
    Jin W, Xu X, Yang T, Hua Z.
    Chin Med J (Engl); 2000 Jul 15; 113(7):662-6. PubMed ID: 11776043
    [Abstract] [Full Text] [Related]

  • 3. Loss of 17p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas.
    Wagata T, Shibagaki I, Imamura M, Shimada Y, Toguchida J, Yandell DW, Ikenaga M, Tobe T, Ishizaki K.
    Cancer Res; 1993 Feb 15; 53(4):846-50. PubMed ID: 8094033
    [Abstract] [Full Text] [Related]

  • 4. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.
    Fults D, Brockmeyer D, Tullous MW, Pedone CA, Cawthon RM.
    Cancer Res; 1992 Feb 01; 52(3):674-9. PubMed ID: 1346255
    [Abstract] [Full Text] [Related]

  • 5. Loss of heterozygosity on chromosome 10, 13q(Rb), 17p, and p53 gene mutations in human brain gliomas.
    Lee SH, Kim JH, Rhee CH, Kang YS, Lee JH, Hong SI, Choi KS.
    J Korean Med Sci; 1995 Dec 01; 10(6):442-8. PubMed ID: 8924230
    [Abstract] [Full Text] [Related]

  • 6. Loss of heterozygosity and tumor suppressor gene mutations in chondrosarcomas.
    Yamaguchi T, Toguchida J, Wadayama B, Kanoe H, Nakayama T, Ishizaki K, Ikenaga M, Kotoura Y, Sasaki MS.
    Anticancer Res; 1996 Dec 01; 16(4A):2009-15. PubMed ID: 8712735
    [Abstract] [Full Text] [Related]

  • 7. Frequent p53 gene mutations in blast crisis of chronic myelogenous leukemia, especially in myeloid crisis harboring loss of a chromosome 17p.
    Nakai H, Misawa S, Toguchida J, Yandell DW, Ishizaki K.
    Cancer Res; 1992 Dec 01; 52(23):6588-93. PubMed ID: 1423304
    [Abstract] [Full Text] [Related]

  • 8. Alterations of the TP53 gene in human gliomas.
    Rasheed BK, McLendon RE, Herndon JE, Friedman HS, Friedman AH, Bigner DD, Bigner SH.
    Cancer Res; 1994 Mar 01; 54(5):1324-30. PubMed ID: 8118823
    [Abstract] [Full Text] [Related]

  • 9. Mutations in the p53 gene in primary human breast cancers.
    Osborne RJ, Merlo GR, Mitsudomi T, Venesio T, Liscia DS, Cappa AP, Chiba I, Takahashi T, Nau MM, Callahan R.
    Cancer Res; 1991 Nov 15; 51(22):6194-8. PubMed ID: 1682043
    [Abstract] [Full Text] [Related]

  • 10. Chromosome 17p deletions and p53 mutations in renal cell carcinoma.
    Reiter RE, Anglard P, Liu S, Gnarra JR, Linehan WM.
    Cancer Res; 1993 Jul 01; 53(13):3092-7. PubMed ID: 8319216
    [Abstract] [Full Text] [Related]

  • 11. Allelic loss of chromosome 17p, mutation of the p53 gene, and microsatellite instability in right- and left-sided colorectal cancer.
    Watatani M, Yoshida T, Kuroda K, Ieda S, Yasutomi M.
    Cancer; 1996 Apr 15; 77(8 Suppl):1688-93. PubMed ID: 8608563
    [Abstract] [Full Text] [Related]

  • 12. Detection of p53 gene mutations in human brain tumors by single-strand conformation polymorphism analysis of polymerase chain reaction products.
    Mashiyama S, Murakami Y, Yoshimoto T, Sekiya T, Hayashi K.
    Oncogene; 1991 Aug 15; 6(8):1313-8. PubMed ID: 1886708
    [Abstract] [Full Text] [Related]

  • 13. Allelic loss on chromosome 17p and p53 mutations in human endometrial carcinoma of the uterus.
    Okamoto A, Sameshima Y, Yamada Y, Teshima S, Terashima Y, Terada M, Yokota J.
    Cancer Res; 1991 Oct 15; 51(20):5632-5. PubMed ID: 1913680
    [Abstract] [Full Text] [Related]

  • 14. Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomas.
    Saxena A, Clark WC, Robertson JT, Ikejiri B, Oldfield EH, Ali IU.
    Cancer Res; 1992 Dec 01; 52(23):6716-21. PubMed ID: 1358438
    [Abstract] [Full Text] [Related]

  • 15. [Mutations of p53 gene in 41 cases of human brain gliomas].
    Cui W, Kong X, Cao HL, Wang X, Gao JF, Wu RL, Wang XC.
    Ai Zheng; 2008 Jan 01; 27(1):8-11. PubMed ID: 18184456
    [Abstract] [Full Text] [Related]

  • 16. Frequent allelic losses and mutations of the p53 gene in human ovarian cancer.
    Okamoto A, Sameshima Y, Yokoyama S, Terashima Y, Sugimura T, Terada M, Yokota J.
    Cancer Res; 1991 Oct 01; 51(19):5171-6. PubMed ID: 1680546
    [Abstract] [Full Text] [Related]

  • 17. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
    Cornelis RS, van Vliet M, Vos CB, Cleton-Jansen AM, van de Vijver MJ, Peterse JL, Khan PM, Børresen AL, Cornelisse CJ, Devilee P.
    Cancer Res; 1994 Aug 01; 54(15):4200-6. PubMed ID: 8033152
    [Abstract] [Full Text] [Related]

  • 18. [Detection of codon 72 polymorphism of p53 gene from blood and loss of heterozygosity in brain tumors using polymerase chain reaction].
    Iijima J, Sawa H, Shiina Y, Hoshino T.
    No To Shinkei; 1993 Jan 01; 45(1):43-7. PubMed ID: 8476653
    [Abstract] [Full Text] [Related]

  • 19. Sites and types of p53 mutations in an unselected series of colorectal cancers in The Netherlands.
    Van Den Broek MH, Renault B, Fodde R, Verspaget H, Griffioen G, Khan PM.
    Anticancer Res; 1993 Jan 01; 13(3):587-92. PubMed ID: 8317886
    [Abstract] [Full Text] [Related]

  • 20. p53 mutations and prognosis in bladder tumors.
    Uchida T, Wada C, Ishida H, Wang C, Egawa S, Yokoyama E, Kameya T, Koshiba K.
    J Urol; 1995 Apr 01; 153(4):1097-104. PubMed ID: 7869472
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.